In this study, use of MEK inhibitors abrogated this effect of ABT-737, and combination treatment with ABT-737 and a MEK inhibitor resulted in potent synergistic killing of AML cell lines, primary AML blasts, and murine xenografts (22). This evidence concerns the gene MAP2K7 and acute myeloid leukemia.